The Stanford MISTIC study: what did ibogaine do for veterans with brain injury?

In the Stanford MISTIC study, veterans with brain injuries took ibogaine with magnesium. A month later, their PTSD, depression and anxiety scores had dropped sharply, and so had their disability scores [1]. By research standards, the drops were large [1]. Ibogaine also strains the heart's rhythm. Treatment needs heart tests first and a close watch on the heart [2].

What was the Stanford MISTIC study?

MISTIC was a Stanford study of ibogaine in veterans with brain injuries. It came out in the journal Nature Medicine in 2024 [1]. The name is short for Magnesium-Ibogaine: the Stanford Traumatic Injury to the CNS protocol [1].

The volunteers were men who had served in Special Operations units [1]. Most had mild brain injuries, often from repeated blasts. Many also lived with PTSD, depression or anxiety. At the start, about three in four met the criteria for PTSD, and about half for major depression and for an anxiety disorder [1]. On average, they had left the forces almost eight years before [1].

The veterans booked their own treatment at a clinic in Mexico, where ibogaine is not restricted [1]. Stanford's team did not give the drug. It tested the men a few days before treatment, a few days after, and again a month later [1].

People who follow ibogaine research tend to ask two things about this study. They want to know how large the change was. They also want to know what a study like this can show. The wider picture sits in Ibogaine: What the Evidence Shows in 2026.

How is ibogaine thought to work on PTSD and brain injury?

Ibogaine acts on many brain targets at once [3]. Addiction is the use studied longest. Even there, a 2019 research paper describes the route to its effect as unresolved [3]. For PTSD and brain injury, what the research documents is what changed in people, and MISTIC measured that in detail.

A drug aimed at one target works like a key cut for a single lock. Ibogaine is more like a loose master key. It fits many locks, none of them tightly [1][3]. It attaches to opioid receptors, to NMDA receptors involved in learning, and to nicotinic receptors [3]. It also binds the pumps that recycle serotonin and dopamine [3].

The MISTIC authors describe ibogaine as an oneirogen, a drug that brings on dream-like states [1]. In their account, that dream-like phase opens into a longer stretch of self-reflection [1].

The targets, and how the body handles the drug, have their own article, The Pharmacology of Ibogaine: Targets, Kinetics, Metabolism.

How large were the effects in the MISTIC study?

The effects in MISTIC were large. One month after treatment, the veterans' average disability score had fallen into the range counted as no disability [1]. In exploratory analyses, at least 83 percent of the veterans were in remission on each of the PTSD, depression and anxiety scales [1].

The study reports its results as effect sizes, written as Cohen's d. Picture a ruler marked off in units of how widely the group's scores were spread. The d value counts how many marks the average score moved. The MISTIC authors call moves of about one mark large [1]. The psychiatric scores moved more than two marks [1].

The main measure was a World Health Organization disability scale, scored from 0 to 100 [1]. The average score fell from 30 before treatment to 20 a few days after it (d = 0.74) [1]. By one month it had reached 5 (d = 2.20) [1].

Trained assessors rated symptoms in structured interviews. Average scores before treatment and one month after [1]:

• PTSD, on the CAPS-5 scale: 31.7 to 4.8, d = 2.54
• Depression, on the MADRS scale: 25.6 to 3.8, d = 2.80
• Anxiety, on the HAM-A scale: 20.8 to 3.9, d = 2.13

An exploratory analysis also tracked each veteran's own drop. At one month, scores had fallen by 88 percent on average for PTSD, 87 percent for depression and 81 percent for anxiety [1].

In another exploratory analysis, 47 percent of the veterans reported some suicidal thoughts before treatment [1]. A few days after treatment, none did. At one month, 7 percent did [1].

No veteran's PTSD, depression or anxiety was worse at one month than at the start [1]. Several had notable symptoms return between the first check and one month [1]. For at least two of them, the authors link this to heavy stress after getting home [1]. Even the largest relapses left people more than 30 percent better than before treatment [1].

The results describe a whole package of care. Veterans had coaching with a licensed therapist before and after treatment [1]. They took part in group preparation and, afterwards, integration sessions [1]. Other studies sit side by side in Every Major Ibogaine Study, Summarized.

Did thinking and the brain change after MISTIC treatment?

Thinking skills improved after treatment, on standard tests given at Stanford [1]. Processing speed showed large gains (d = 0.97 to 1.34) [1]. Processing speed is how quickly a person takes in and handles information.

Executive function improved as well [1]. These are the skills used to plan, to switch between tasks and to hold back an impulse. Average scores rose from the typical range to high average for the veterans' age [1]. Visual memory improved at both follow-up checks [1]. No area of thinking got worse [1].

The authors used these tests partly to gauge the role of placebo [1]. Scores on tests like these are hard to shift by expectation [1].

Brain scans of the same veterans showed change too. After treatment, the outer layer of the brain had thickened in 11 regions [5]. A computer model trained on healthy aging rated the scans as resembling brains about 1.3 years younger [5]. The authors describe the overall pattern as consistent with neuroplasticity, the brain's capacity to rebuild its connections [5].

The inner experience also tracked the outcome. Veterans who rated their experience as more mystical had larger drops in PTSD symptoms [7]. The link held both a few days after treatment and at one month [7].

Why was magnesium given with ibogaine, and what did the heart show?

MISTIC added magnesium to protect the heart. Ibogaine lengthens the QT interval [1]. That is the time the heart takes to reset its charge between beats. A long QT has been linked to sudden deaths after ibogaine [3]. Magnesium can shorten the QT. It can also guard against the QT stretch that some other drugs cause [1].

Each veteran got 1 gram of magnesium through a drip, one to two hours before ibogaine [1]. Ibogaine came by mouth, starting with a small test dose [1]. Staff added more within two hours, to a total under 14 mg per kg of body weight [1]. The average total was about 12 mg per kg [1]. A second magnesium drip came about 12 hours later [1].

Before dosing, the clinic ran blood tests and an EKG [1]. Veterans stopped drugs that clash with ibogaine, including all drugs for mental health [1]. People with heart, liver or kidney problems could not take part [1]. During treatment, medically trained staff were on hand, at least one for every two patients [1]. A heart monitor ran without a break for 12 to 16 hours [1].

On that monitor, read by eye, staff saw no QT lengthening of medical concern [1]. There were no serious or unexpected side effects [1]. Every veteran had brief unsteadiness and tremor that cleared within 24 hours [1]. During the session, 40 percent needed treatment for headache and 23 percent for nausea [1].

The QT effect itself is well known. In a Dutch hospital study of people dependent on opioids, half passed a QT of 500 milliseconds after one ibogaine dose [2]. In close to half, the lengthening lasted beyond 24 hours [2]. The body also turns ibogaine into a second compound, noribogaine [8]. Noribogaine stays in the blood for days, with a half-life of 24 to 30 hours [6]. Given on its own, it also lengthens the QT interval [6].

The MISTIC authors name high doses, existing health problems, drug clashes and a lack of vital-sign monitoring as factors that may have played a part in past deaths [1]. Screening and monitoring target those factors. They lower the risk without removing it [1][2]. The long tail of noribogaine has its own article, Noribogaine: Pharmacokinetics of the Long Tail.

What did veterans go through during the treatment?

The veterans described the treatment as a waking dream about their own lives [9]. Many relived old memories, war among them, and saw them in a new light [9].

The dose came in the evening, after a day of group preparation and an eight-hour fast [1]. Each veteran lay on a mat in a shared room, wearing eye shades [1][9]. No therapy took place during the session [1]. Staff stayed close in case anyone needed support [1].

The effects come in stages. A dream-like stage lasts about 4 to 8 hours [1][10]. A calmer stage of looking back follows, lasting about 8 to 20 hours [1][10]. Then come one to three days as the last effects fade [1].

Afterwards, the veterans wrote about what they went through. Researchers found four common threads in their accounts [9]:

- Hard memories replayed, often with a feeling of love, forgiveness or acceptance - A sense of watching from outside, or of the self melting into something larger - Sudden waves of love for family and friends - Body sensations that veterans took as their brain healing

One veteran recalled carrying a fallen door gunner after a helicopter was shot down. When that memory returned, he wrote, the pain he had carried for years went away [9]. Another said his sense of self felt put on hold, as if he were just watching the scenes [9].

Many spoke of the experience as a guide or a teacher that talked with them [9]. The researchers see the brain-healing feelings as the body's own picture of recovery [9]. Some veterans also noticed changes once home, such as fewer cravings and a better mood [9].

Where the research goes next

MISTIC was an open-label study of 30 veterans with a single treatment group [1]. Its design supports two conclusions. The size of the change justifies larger controlled trials, which is how the authors close their paper [1]. The magnesium protocol, with its screening and monitoring, gives those trials a starting point [1].

The first next step is a randomized trial with a comparison group. It would show how much of the change comes from ibogaine and how much from coaching, setting and expectation [1]. The authors expect blinding to be hard, because ibogaine's dream-like effects are hard to disguise [1].

Second is longer follow-up. A twelve-month report on 25 of the veterans, posted as a preprint and not yet peer reviewed, describes gains that held [4]. It estimates sustained remission at twelve months for 84 percent with PTSD, 66 percent with depression and 61 percent with anxiety [4].

Third is a wider range of people. The authors call for studies in more diverse groups, in more severe brain injury and in people with more complex health problems [1]. Suicidal thoughts also need scales built to measure them [1].

Fourth is heart data in numbers. A trial could record the QT interval at set times and compare ibogaine with and without magnesium [1][2].

Last is replication by independent teams. Three co-authors held shares in the company that ran the treatment, and two had filed a patent application on the protocol's safety [1]. What the field needs to answer next is set out in Open Questions: What Rigorous Ibogaine Trials Must Answer.

Frequently asked questions

What did the Stanford ibogaine study find?

A month after ibogaine with magnesium, veterans with brain injuries scored far lower for PTSD, depression and anxiety [1]. Their disability scores fell too [1]. The effect sizes for mental health ran from 2.13 to 2.80, which the authors call large [1]. Thinking speed and planning skills also improved [1].

Does ibogaine help veterans with PTSD?

In MISTIC, the average PTSD score fell from 31.7 to 4.8 a month after treatment [1]. An exploratory analysis put the average drop for each veteran at 88 percent [1]. A randomized trial is the next step [1].

How does ibogaine help with traumatic brain injury?

In veterans with mostly mild brain injury, disability scores fell and thinking skills got better after treatment [1]. Brain scans of the same men showed a thicker outer layer of the brain in 11 regions [5]. How ibogaine does this is still being worked out, even for addiction [3].

What does ibogaine do to the brain?

Ibogaine binds many targets at once [3]. These include opioid receptors and the pumps that recycle serotonin and dopamine [3]. In rats, a high dose raised GDNF, a protein that helps nerve cells survive [3]. In veterans, brain scans after treatment fit with the brain building new links [5].

What are the side effects of magnesium-ibogaine?

In MISTIC, every veteran had brief unsteadiness and a tremor that cleared within a day [1]. During the session, 40 percent needed help for headache and 23 percent for nausea [1]. No serious or unexpected side effects occurred [1].

Is ibogaine safe?

Ibogaine stretches the heart's QT interval, and a long QT has been linked to sudden deaths [3]. In one hospital study of people dependent on opioids, half passed a QT of 500 milliseconds after a single dose [2]. Treatment needs screening and nonstop heart monitoring. These lower the risk without removing it [1][2].